PT81498B
(pt)
*
|
1984-11-23 |
1987-12-30 |
Schering Ag |
Processo para a preparacao de composicoes para diagnostico contendo particulas magneticas
|
US4795698A
(en)
*
|
1985-10-04 |
1989-01-03 |
Immunicon Corporation |
Magnetic-polymer particles
|
US5512332A
(en)
*
|
1985-10-04 |
1996-04-30 |
Immunivest Corporation |
Process of making resuspendable coated magnetic particles
|
US5597531A
(en)
*
|
1985-10-04 |
1997-01-28 |
Immunivest Corporation |
Resuspendable coated magnetic particles and stable magnetic particle suspensions
|
US5262176A
(en)
*
|
1986-07-03 |
1993-11-16 |
Advanced Magnetics, Inc. |
Synthesis of polysaccharide covered superparamagnetic oxide colloids
|
US5102652A
(en)
*
|
1986-07-03 |
1992-04-07 |
Advanced Magnetics Inc. |
Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
|
US5219554A
(en)
|
1986-07-03 |
1993-06-15 |
Advanced Magnetics, Inc. |
Hydrated biodegradable superparamagnetic metal oxides
|
US4951675A
(en)
*
|
1986-07-03 |
1990-08-28 |
Advanced Magnetics, Incorporated |
Biodegradable superparamagnetic metal oxides as contrast agents for MR imaging
|
US5160726A
(en)
*
|
1990-02-15 |
1992-11-03 |
Advanced Magnetics Inc. |
Filter sterilization for production of colloidal, superparamagnetic MR contrast agents
|
US5248492A
(en)
*
|
1986-07-03 |
1993-09-28 |
Advanced Magnetics, Inc. |
Low molecular weight carbohydrates as additives to stabilize metal oxide compositions
|
DE3709851A1
(de)
*
|
1987-03-24 |
1988-10-06 |
Silica Gel Gmbh Adsorptions Te |
Nmr-diagnostische fluessigkeitszusammensetzungen
|
US5395688A
(en)
*
|
1987-10-26 |
1995-03-07 |
Baxter Diagnostics Inc. |
Magnetically responsive fluorescent polymer particles
|
US6013531A
(en)
*
|
1987-10-26 |
2000-01-11 |
Dade International Inc. |
Method to use fluorescent magnetic polymer particles as markers in an immunoassay
|
DE3852299T2
(de)
*
|
1987-10-26 |
1995-07-20 |
Baxter Diagnostics Inc |
Verfahren zur herstellung magnetisch empfindlicher polymerteilchen und deren anwendung.
|
DE3807904A1
(de)
*
|
1988-03-10 |
1989-09-21 |
Behringwerke Ag |
Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
|
US5236824A
(en)
*
|
1988-04-26 |
1993-08-17 |
Nippon Telegraph And Telephone Corporation |
Laser magnetic immunoassay method and method by a magnetophoresis apparatus therefor
|
EP0339623B1
(de)
*
|
1988-04-26 |
1993-12-15 |
Nippon Telegraph And Telephone Corporation |
Lasermagnetisches Immuntestverfahren und Gerät dazu
|
US5238811A
(en)
*
|
1988-04-26 |
1993-08-24 |
Nippon Telegraph And Telephone Corporation |
Laser magnetic immunoassay method and apparatus therefor and superparamagnetic material-labeled body and method for the manufacture of same
|
GB8813682D0
(en)
*
|
1988-06-09 |
1988-07-13 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions
|
US5145661A
(en)
*
|
1988-08-31 |
1992-09-08 |
Wayne State University |
Method and contrast agent for use in magnetic resonance imaging of abscess
|
US5108933A
(en)
*
|
1988-09-16 |
1992-04-28 |
Immunicon Corporation |
Manipulation of colloids for facilitating magnetic separations
|
ES2080740T3
(es)
*
|
1988-11-14 |
1996-02-16 |
Akzo Nobel Nv |
Suspension acuosa para ensayos de diagnostico.
|
JPH02210262A
(ja)
*
|
1989-02-10 |
1990-08-21 |
Shinotesuto Kenkyusho:Kk |
間接凝集反応測定法
|
US5114703A
(en)
*
|
1989-05-30 |
1992-05-19 |
Alliance Pharmaceutical Corp. |
Percutaneous lymphography using particulate fluorocarbon emulsions
|
DE3919873A1
(de)
*
|
1989-06-19 |
1990-12-20 |
Behringwerke Ag |
Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
|
US5178834A
(en)
*
|
1989-07-19 |
1993-01-12 |
Tosoh Corporation |
Automatic immunoassay analyzer
|
US5698271A
(en)
*
|
1989-08-22 |
1997-12-16 |
Immunivest Corporation |
Methods for the manufacture of magnetically responsive particles
|
FR2656318B1
(fr)
*
|
1989-12-27 |
1994-02-04 |
Rhone Poulenc Chimie |
Microspheres "core-shell" magnetisables a base d'organopolysiloxane reticule, leur procede de preparation et leur application en biologie.
|
FR2656317B1
(fr)
*
|
1989-12-27 |
1994-02-04 |
Rhone Poulenc Chimie |
Microspheres magnetisables a base de polysilsesquioxane, leur procede de preparation et leur application en biologie.
|
ATE135920T1
(de)
|
1990-02-15 |
1996-04-15 |
Advanced Magnetics Inc |
Filtersterilisation zur herstellung von kolloidalen superparamagnetischen mr- kontrastmitteln und ihre verwendung
|
GB9006977D0
(en)
*
|
1990-03-28 |
1990-05-23 |
Nycomed As |
Compositions
|
US5254460A
(en)
*
|
1990-05-03 |
1993-10-19 |
Advanced Magnetics, Inc. |
Solvent mediated relaxation assay system
|
US5164297A
(en)
*
|
1990-05-03 |
1992-11-17 |
Advanced Magnetics Inc. |
Solvent mediated relaxation assay system
|
US5240640A
(en)
*
|
1990-06-04 |
1993-08-31 |
Coulter Corporation |
In situ use of gelatin or an aminodextran in the preparation of uniform ferrite particles
|
IL98744A0
(en)
*
|
1990-07-06 |
1992-07-15 |
Gen Hospital Corp |
Method of studying biological tissue using monocrystalline particles
|
US6013532A
(en)
*
|
1990-09-26 |
2000-01-11 |
Immunivest Corporation |
Methods for magnetic immobilization and manipulation of cells
|
US5622831A
(en)
*
|
1990-09-26 |
1997-04-22 |
Immunivest Corporation |
Methods and devices for manipulation of magnetically collected material
|
US5200084A
(en)
*
|
1990-09-26 |
1993-04-06 |
Immunicon Corporation |
Apparatus and methods for magnetic separation
|
US5169754A
(en)
*
|
1990-10-31 |
1992-12-08 |
Coulter Corporation |
Biodegradable particle coatings having a protein covalently immobilized by means of a crosslinking agent and processes for making same
|
US5639620A
(en)
*
|
1990-10-31 |
1997-06-17 |
Coulter Corporation |
Polymeric particles having a biodegradable gelatin or aminodextran coating and process for making same
|
US5466609A
(en)
*
|
1990-10-31 |
1995-11-14 |
Coulter Corporation |
Biodegradable gelatin-aminodextran particle coatings of and processes for making same
|
ATE179894T1
(de)
*
|
1991-01-19 |
1999-05-15 |
Meito Sangyo Kk |
Ultrafeine magnetische metalloxideteilchen enthaltende zusammensetzung
|
US5370901A
(en)
*
|
1991-02-15 |
1994-12-06 |
Bracco International B.V. |
Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
|
US5242833A
(en)
*
|
1991-03-20 |
1993-09-07 |
Reference Diagnostics, Inc. |
Lipid fractionation
|
US5795470A
(en)
*
|
1991-03-25 |
1998-08-18 |
Immunivest Corporation |
Magnetic separation apparatus
|
US5466574A
(en)
*
|
1991-03-25 |
1995-11-14 |
Immunivest Corporation |
Apparatus and methods for magnetic separation featuring external magnetic means
|
US5646001A
(en)
*
|
1991-03-25 |
1997-07-08 |
Immunivest Corporation |
Affinity-binding separation and release of one or more selected subset of biological entities from a mixed population thereof
|
US5186827A
(en)
*
|
1991-03-25 |
1993-02-16 |
Immunicon Corporation |
Apparatus for magnetic separation featuring external magnetic means
|
PH29904A
(en)
*
|
1991-03-27 |
1996-09-16 |
Salutar Inc |
Contrast media
|
CA2065719A1
(en)
|
1991-04-30 |
1992-10-31 |
John B. Findlay |
Nucleic acid amplification and detection methods using rapid polymerase chain reaction cycle
|
IT1252145B
(it)
*
|
1991-11-29 |
1995-06-05 |
Bracco Ind Chimica Spa |
Metodo e formulazioni adatte a migliorare lo studio degli organi cavi nell'uomo
|
US5225282A
(en)
*
|
1991-12-13 |
1993-07-06 |
Molecular Bioquest, Inc. |
Biodegradable magnetic microcluster comprising non-magnetic metal or metal oxide particles coated with a functionalized polymer
|
US5248772A
(en)
*
|
1992-01-29 |
1993-09-28 |
Coulter Corporation |
Formation of colloidal metal dispersions using aminodextrans as reductants and protective agents
|
GB2265004B
(en)
*
|
1992-03-10 |
1996-01-10 |
Univ Cardiff |
Immuno-agglutination assay using ultrasonic standing wave field
|
US5334471A
(en)
*
|
1992-07-02 |
1994-08-02 |
Xerox Corporation |
Low gloss encapsulated compositions
|
CA2146964C
(en)
*
|
1992-10-15 |
2005-11-29 |
Olavi Siiman |
Particles having gelatin-aminodextran coatings of and processes for making same
|
US5349957A
(en)
*
|
1992-12-02 |
1994-09-27 |
Sterling Winthrop Inc. |
Preparation and magnetic properties of very small magnetite-dextran particles
|
US5855790A
(en)
*
|
1994-02-07 |
1999-01-05 |
Selective Environmental Technologies, Inc. |
Magnetic particles, a method for the preparation thereof and their use in the purification of solutions
|
ATE176077T1
(de)
*
|
1994-07-07 |
1999-02-15 |
Chiron Diagnostics Corp |
Hochdispergierte magnetische metalloxidteilchen,produktionsverfahren und anwendung
|
US5871625A
(en)
|
1994-08-25 |
1999-02-16 |
University Of Iowa Research Foundation |
Magnetic composites for improved electrolysis
|
US6001248A
(en)
|
1994-08-25 |
1999-12-14 |
The University Of Iowa Research Foundation |
Gradient interface magnetic composites and systems therefor
|
US5622822A
(en)
|
1994-09-13 |
1997-04-22 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Methods for capture and selective release of nucleic acids using polyethyleneimine and an anionic phosphate ester surfactant and amplification of same
|
US5582988A
(en)
|
1994-09-15 |
1996-12-10 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Methods for capture and selective release of nucleic acids using weakly basic polymer and amplification of same
|
US5705366A
(en)
*
|
1994-09-15 |
1998-01-06 |
Johnson & Johnson Clinical Diagnostics, Inc. |
Coamplification of target nucleic acids using volume exclusion agent in reaction composition, test kit and test device useful therefor
|
US5693784A
(en)
*
|
1994-09-19 |
1997-12-02 |
Promega Corporation |
Methods for creating agglomerates from colloidal particles
|
US5750339A
(en)
*
|
1994-11-30 |
1998-05-12 |
Thomas Jefferson University |
Methods for identifying fetal cells
|
EP0873358A2
(de)
*
|
1995-01-13 |
1998-10-28 |
Innogenetics N.V. |
Einfangen von mikroorganismen mittels komplement komponenten
|
US5705059A
(en)
*
|
1995-02-27 |
1998-01-06 |
Miltenyi; Stefan |
Magnetic separation apparatus
|
US5741714A
(en)
*
|
1995-07-18 |
1998-04-21 |
Immunivest Corporation |
Detection of bound analyte by magnetic partitioning and masking
|
US5660990A
(en)
*
|
1995-08-18 |
1997-08-26 |
Immunivest Corporation |
Surface immobilization of magnetically collected materials
|
CA2242647A1
(en)
|
1996-01-10 |
1997-07-17 |
Amersham Health As |
Contrast media
|
GB9600427D0
(en)
*
|
1996-01-10 |
1996-03-13 |
Nycomed Imaging As |
Contrast media
|
DE19606598C1
(de)
*
|
1996-02-22 |
1997-11-13 |
Innova Gmbh |
Magnetpartikel mit biologisch aktiven Rezeptoren sowie Herstellung und Verwendung
|
CA2255599C
(en)
|
1996-04-25 |
2006-09-05 |
Bioarray Solutions, Llc |
Light-controlled electrokinetic assembly of particles near surfaces
|
FR2758884B1
(fr)
|
1997-01-30 |
1999-04-02 |
Bio Merieux |
Procede pour isoler, notamment detecter ou quantifier un analyte dans un milieu
|
FR2762394B1
(fr)
*
|
1997-04-16 |
1999-05-28 |
Bio Merieux |
Compose ligand de coordination et utilisation pour fixer un materiel biologique
|
JP2002511141A
(ja)
|
1997-06-18 |
2002-04-09 |
イノーファ・ゲゼルシャフト・ツーァ・エントヴィックルング・ウント・フェアマルクトゥング・イノファティファー・プロドゥクテ・エムベーハー |
生物学的活性レセプターを有する磁性粒子
|
US6241894B1
(en)
*
|
1997-10-10 |
2001-06-05 |
Systemix |
High gradient magnetic device and method for cell separation or purification
|
US6337215B1
(en)
|
1997-12-01 |
2002-01-08 |
International Business Machines Corporation |
Magnetic particles having two antiparallel ferromagnetic layers and attached affinity recognition molecules
|
JP2002503814A
(ja)
*
|
1998-02-12 |
2002-02-05 |
イムニベスト・コーポレイション |
循環ガン細胞の迅速かつ効率的な単離のための方法および試薬
|
US20010018192A1
(en)
*
|
1998-02-12 |
2001-08-30 |
Terstappen Leon W.M.M. |
Labeled cells for use as an internal functional control in rare cell detection assays
|
US7282350B2
(en)
|
1998-02-12 |
2007-10-16 |
Immunivest Corporation |
Labeled cell sets for use as functional controls in rare cell detection assays
|
US6908770B1
(en)
|
1998-07-16 |
2005-06-21 |
Board Of Regents, The University Of Texas System |
Fluid based analysis of multiple analytes by a sensor array
|
US6368866B1
(en)
|
1998-08-03 |
2002-04-09 |
Reference Diagnostics, Inc. |
Rapid separation assay for total iron binding capacity
|
US6361749B1
(en)
|
1998-08-18 |
2002-03-26 |
Immunivest Corporation |
Apparatus and methods for magnetic separation
|
US6551843B1
(en)
|
1999-01-29 |
2003-04-22 |
Immunivest Corporation |
Methods for enhancing binding interactions between members of specific binding pairs
|
EP1177424A4
(de)
|
1999-04-09 |
2005-04-06 |
Shot Inc |
Elektromagnetisches mehrphasen-trenngerät zur reinigung von zellen, chemikalien und protein-strukturen
|
US20040058401A1
(en)
*
|
1999-04-13 |
2004-03-25 |
Blaise Bossy |
Method for detecting rare event
|
ES2228520T3
(es)
*
|
1999-05-04 |
2005-04-16 |
Ortho-Clinical Diagnostics, Inc. |
Capatura rapida y eficaz de adn de una muestra sin usar reactivo de lisis celular.
|
US6623982B1
(en)
*
|
1999-07-12 |
2003-09-23 |
Immunivest Corporation |
Increased separation efficiency via controlled aggregation of magnetic nanoparticles
|
AU1429701A
(en)
|
1999-07-16 |
2001-02-05 |
Board Of Regents, The University Of Texas System |
General signaling protocols for chemical receptors in immobilized matrices
|
US7022517B1
(en)
|
1999-07-16 |
2006-04-04 |
Board Of Regents, The University Of Texas System |
Method and apparatus for the delivery of samples to a chemical sensor array
|
AU2001247195A1
(en)
|
2000-01-31 |
2001-08-07 |
Board Of Regents, The University Of Texas System |
Method and system for collecting and transmitting chemical information
|
US7262006B1
(en)
|
2000-05-01 |
2007-08-28 |
Ortho-Clinical Diagnostics, Inc. |
Rapid and efficient capture of DNA from sample without using cell lysing reagent
|
US9709559B2
(en)
|
2000-06-21 |
2017-07-18 |
Bioarray Solutions, Ltd. |
Multianalyte molecular analysis using application-specific random particle arrays
|
US7892854B2
(en)
*
|
2000-06-21 |
2011-02-22 |
Bioarray Solutions, Ltd. |
Multianalyte molecular analysis using application-specific random particle arrays
|
US7169618B2
(en)
|
2000-06-28 |
2007-01-30 |
Skold Technology |
Magnetic particles and methods of producing coated magnetic particles
|
EP1312671B1
(de)
|
2000-08-21 |
2009-04-01 |
National Institute of Advanced Industrial Science and Technology |
Magnetische partikel mit kritischer lösungstemperatur am unteren bereich
|
GB2368909B
(en)
*
|
2000-11-09 |
2004-09-22 |
Amersham Pharm Biotech Uk Ltd |
Separation particles
|
US6649419B1
(en)
*
|
2000-11-28 |
2003-11-18 |
Large Scale Proteomics Corp. |
Method and apparatus for protein manipulation
|
EP1373874A4
(de)
*
|
2001-01-31 |
2004-03-31 |
Univ Texas |
Verfahren und vorrichtung zum eingrenzen von materialien in einem mikrobearbeiteten chemischen sensorarray
|
US20020160363A1
(en)
*
|
2001-01-31 |
2002-10-31 |
Mcdevitt John T. |
Magnetic-based placement and retention of sensor elements in a sensor array
|
WO2002063270A2
(en)
*
|
2001-02-05 |
2002-08-15 |
Board Of Regents, The University Of Texas System |
The use of mesoscale self-assembly and recognition to effect delivery of sensing reagent for arrayed sensors
|
US7262063B2
(en)
|
2001-06-21 |
2007-08-28 |
Bio Array Solutions, Ltd. |
Directed assembly of functional heterostructures
|
FR2826592B1
(fr)
|
2001-06-27 |
2003-08-15 |
Bio Merieux |
Procede, dispositif, et equipement de separation par voie humide de micro particules magnetiques
|
US7863012B2
(en)
*
|
2004-02-17 |
2011-01-04 |
Veridex, Llc |
Analysis of circulating tumor cells, fragments, and debris
|
US20040106109A1
(en)
*
|
2001-10-02 |
2004-06-03 |
Belly Robert T |
Detection of ras mutations
|
KR20040068122A
(ko)
|
2001-10-15 |
2004-07-30 |
바이오어레이 솔루션스 리미티드 |
공동 검색과 효소-매개된 탐지에 의한 다형성 좌위의 다중분석
|
US7018849B2
(en)
*
|
2002-01-15 |
2006-03-28 |
Piasio Roger N |
Process for (A) separating biological/ligands from dilute solutions and (B) conducting an immunochromatographic assay thereof employing superparamagnetic particles throughtout
|
US6792019B2
(en)
*
|
2002-02-28 |
2004-09-14 |
Texas Instruments Incorporated |
Driver with tail currents in discrete subranges
|
US7214427B2
(en)
*
|
2002-03-21 |
2007-05-08 |
Aviva Biosciences Corporation |
Composite beads comprising magnetizable substance and electro-conductive substance
|
US7514270B2
(en)
*
|
2002-04-12 |
2009-04-07 |
Instrumentation Laboratory Company |
Immunoassay probe
|
CA2523626A1
(en)
|
2002-04-26 |
2003-11-06 |
Board Of Regents, The University Of Texas System |
Method and system for the detection of cardiac risk factors
|
WO2004039830A2
(en)
*
|
2002-05-07 |
2004-05-13 |
Regents Of The University Of California |
Bioactivation of particles
|
US20040229380A1
(en)
*
|
2002-05-21 |
2004-11-18 |
Po-Ying Chan-Hui |
ErbB heterodimers as biomarkers
|
EP1546367A4
(de)
*
|
2002-07-24 |
2006-08-16 |
Univ Texas |
Einfang und nachweis von mikroben mit membranverfahren
|
US7526114B2
(en)
|
2002-11-15 |
2009-04-28 |
Bioarray Solutions Ltd. |
Analysis, secure access to, and transmission of array images
|
US20040109824A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Hinds Kathleen Allison |
Particles for imaging cells
|
US7255895B2
(en)
*
|
2003-01-21 |
2007-08-14 |
Bioarray Solutions, Ltd. |
Method for controlling solute loading of polymer microparticles
|
US6964747B2
(en)
*
|
2003-01-21 |
2005-11-15 |
Bioarray Solutions, Ltd. |
Production of dyed polymer microparticles
|
US6873241B1
(en)
|
2003-03-24 |
2005-03-29 |
Robert O. Sanchez |
High frequency transformers and high Q factor inductors formed using epoxy-based magnetic polymer materials
|
EP1608295B1
(de)
|
2003-03-28 |
2017-05-03 |
Covidien LP |
Zweiseitige intravaskuläre medizinische vorrichtung
|
WO2004092353A2
(en)
|
2003-04-01 |
2004-10-28 |
Monogram Biosciences, Inc. |
Surface receptor complexes as biomarkers
|
WO2004097371A2
(en)
*
|
2003-04-25 |
2004-11-11 |
Board Of Regents, The University Of Texas System |
System and method for the detection of analytes
|
US7651850B2
(en)
*
|
2003-05-16 |
2010-01-26 |
Board Of Regents, The University Of Texas System |
Image and part recognition technology
|
US9317922B2
(en)
|
2003-05-16 |
2016-04-19 |
Board Of Regents The University Of Texas System |
Image and part recognition technology
|
AR047692A1
(es)
*
|
2003-07-10 |
2006-02-08 |
Epix Medical Inc |
Imagenes de blancos estacionarios
|
US7402398B2
(en)
*
|
2003-07-17 |
2008-07-22 |
Monogram Biosciences, Inc. |
Measuring receptor homodimerization
|
EP2402089A1
(de)
|
2003-07-31 |
2012-01-04 |
Handylab, Inc. |
Verarbeitung partikelhaltiger Proben
|
NZ545873A
(en)
*
|
2003-08-11 |
2009-05-31 |
Monogram Biosciences Inc |
Detecting and profiling molecular complexes
|
WO2005029705A2
(en)
*
|
2003-09-18 |
2005-03-31 |
Bioarray Solutions, Ltd. |
Number coding for identification of subtypes of coded types of solid phase carriers
|
CA2539824C
(en)
*
|
2003-09-22 |
2015-02-03 |
Xinwen Wang |
Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules
|
AU2004286252A1
(en)
|
2003-10-28 |
2005-05-12 |
Bioarray Solutions Ltd. |
Optimization of gene expression analysis using immobilized capture probes
|
US20050089916A1
(en)
*
|
2003-10-28 |
2005-04-28 |
Xiongwu Xia |
Allele assignment and probe selection in multiplexed assays of polymorphic targets
|
WO2005045060A2
(en)
|
2003-10-29 |
2005-05-19 |
Bioarray Solutions, Ltd. |
Multiplexed nucleic acid analysis by fragmentation of double-stranded dna
|
AU2003285133A1
(en)
*
|
2003-11-05 |
2005-06-24 |
The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services |
Biofunctionalized quantum dots for biological imaging
|
US20050106577A1
(en)
*
|
2003-11-17 |
2005-05-19 |
Hashem Akhavan-Tafti |
Cleavable solid phases for isolating nucleic acids
|
US20050106576A1
(en)
*
|
2003-11-17 |
2005-05-19 |
Hashem Akhavan-Tafti |
Methods of using cleavable solid phases for isolating nucleic acids
|
AU2004237844B2
(en)
|
2003-12-23 |
2011-01-27 |
Therakos, Inc. |
Extracorporeal photopheresis in combination with anti-TNF treatment
|
US20050181353A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Rao Galla C. |
Stabilization of cells and biological specimens for analysis
|
US8101431B2
(en)
*
|
2004-02-27 |
2012-01-24 |
Board Of Regents, The University Of Texas System |
Integration of fluids and reagents into self-contained cartridges containing sensor elements and reagent delivery systems
|
US20060257991A1
(en)
*
|
2004-02-27 |
2006-11-16 |
Mcdevitt John T |
Integration of fluids and reagents into self-contained cartridges containing particle-based sensor elements and membrane-based sensor elements
|
US8105849B2
(en)
*
|
2004-02-27 |
2012-01-31 |
Board Of Regents, The University Of Texas System |
Integration of fluids and reagents into self-contained cartridges containing sensor elements
|
US7781226B2
(en)
*
|
2004-02-27 |
2010-08-24 |
The Board Of Regents Of The University Of Texas System |
Particle on membrane assay system
|
US20060257854A1
(en)
*
|
2004-02-27 |
2006-11-16 |
Mcdevitt John T |
Membrane assay system including preloaded particles
|
US8852862B2
(en)
|
2004-05-03 |
2014-10-07 |
Handylab, Inc. |
Method for processing polynucleotide-containing samples
|
US8211386B2
(en)
*
|
2004-06-08 |
2012-07-03 |
Biokit, S.A. |
Tapered cuvette and method of collecting magnetic particles
|
WO2006093516A2
(en)
*
|
2004-06-22 |
2006-09-08 |
The Regents Of The University Of California |
Peptide-coated nanoparticles with graded shell compositions
|
US7363170B2
(en)
*
|
2004-07-09 |
2008-04-22 |
Bio Array Solutions Ltd. |
Transfusion registry network providing real-time interaction between users and providers of genetically characterized blood products
|
US7848889B2
(en)
|
2004-08-02 |
2010-12-07 |
Bioarray Solutions, Ltd. |
Automated analysis of multiplexed probe-target interaction patterns: pattern matching and allele identification
|
JP4999103B2
(ja)
|
2004-10-27 |
2012-08-15 |
セフィード |
閉鎖系の多段階核酸増幅反応
|
US7939267B2
(en)
*
|
2004-11-04 |
2011-05-10 |
Laboratory Corporation Of America Holdings |
Detection of activation of endothelial cells as surrogate marker for angiogenesis
|
TWI277632B
(en)
*
|
2004-12-14 |
2007-04-01 |
Nat Univ Chung Cheng |
Magnetic polymer microbeads and a method for preparing the same
|
WO2006112771A1
(en)
*
|
2005-04-18 |
2006-10-26 |
Ge Healthcare Bio-Sciences Ab |
Magnetic beads
|
US7749445B2
(en)
*
|
2005-05-02 |
2010-07-06 |
Bioscale, Inc. |
Method and apparatus for analyzing bioprocess fluids
|
US7648844B2
(en)
*
|
2005-05-02 |
2010-01-19 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using an acoustic device
|
US7611908B2
(en)
*
|
2005-05-02 |
2009-11-03 |
Bioscale, Inc. |
Method and apparatus for therapeutic drug monitoring using an acoustic device
|
US7300631B2
(en)
|
2005-05-02 |
2007-11-27 |
Bioscale, Inc. |
Method and apparatus for detection of analyte using a flexural plate wave device and magnetic particles
|
US8377398B2
(en)
|
2005-05-31 |
2013-02-19 |
The Board Of Regents Of The University Of Texas System |
Methods and compositions related to determination and use of white blood cell counts
|
US8486629B2
(en)
|
2005-06-01 |
2013-07-16 |
Bioarray Solutions, Ltd. |
Creation of functionalized microparticle libraries by oligonucleotide ligation or elongation
|
CN1700015B
(zh)
*
|
2005-06-20 |
2010-10-06 |
张爱华 |
组件式多功能传感器件
|
EP2508867A1
(de)
*
|
2005-06-24 |
2012-10-10 |
Board Of Regents, The University Of Texas System |
Systeme und Verfahren einschliesslich in sich geschlossener Kassetten mit Nachweissystemen und Flüssigkeitszufuhrsystemen
|
US20090215646A1
(en)
*
|
2005-07-01 |
2009-08-27 |
The Board Of Regents Of The University Of Texas Sy |
System and method of analyte detection using differential receptors
|
US7901950B2
(en)
*
|
2005-08-12 |
2011-03-08 |
Veridex, Llc |
Method for assessing disease states by profile analysis of isolated circulating endothelial cells
|
US9169461B2
(en)
|
2005-11-02 |
2015-10-27 |
Therakos, Inc. |
Use of apoptotic cells ex vivo to generate regulatory T cells
|
DE102005058979A1
(de)
*
|
2005-12-09 |
2007-06-21 |
Qiagen Gmbh |
Magnetische Polymerpartikel
|
JP5415253B2
(ja)
|
2006-03-24 |
2014-02-12 |
ハンディラブ・インコーポレーテッド |
微小流体サンプルを処理するための一体化システム及びその使用方法
|
US10900066B2
(en)
|
2006-03-24 |
2021-01-26 |
Handylab, Inc. |
Microfluidic system for amplifying and detecting polynucleotides in parallel
|
US11806718B2
(en)
|
2006-03-24 |
2023-11-07 |
Handylab, Inc. |
Fluorescence detector for microfluidic diagnostic system
|
US7998708B2
(en)
|
2006-03-24 |
2011-08-16 |
Handylab, Inc. |
Microfluidic system for amplifying and detecting polynucleotides in parallel
|
US8492097B2
(en)
|
2006-04-24 |
2013-07-23 |
Diagnostic Hybrids, Inc. |
Compositions and methods for human metapneumovirus monoclonal antibodies
|
CN101600966B
(zh)
*
|
2006-06-02 |
2014-07-02 |
辉瑞产品公司 |
循环肿瘤细胞分析
|
BRPI0716157A2
(pt)
*
|
2006-09-05 |
2013-09-17 |
Ct Brasileiro De Pesquisa Fisica Cbpf |
processo para produÇço microcÁpsulas dotadas de propriedades magnÉticas, produto obtido e mÉtodo para a liberaÇço controlada de substÂncias ativas
|
WO2008060604A2
(en)
|
2006-11-14 |
2008-05-22 |
Handylab, Inc. |
Microfluidic system for amplifying and detecting polynucleotides in parallel
|
WO2008131039A2
(en)
*
|
2007-04-16 |
2008-10-30 |
Board Of Regents, The University Of Texas System |
Cardibioindex/cardibioscore and utility of salivary proteome in cardiovascular diagnostics
|
RU2485152C2
(ru)
|
2007-06-05 |
2013-06-20 |
Бэнк оф Канада |
Составы печатной краски или тонера, способы их применения и продукты, получаемые из них
|
CA2693654C
(en)
|
2007-07-13 |
2018-02-13 |
Handylab, Inc. |
Polynucleotide capture materials, and methods of using same
|
US8287820B2
(en)
|
2007-07-13 |
2012-10-16 |
Handylab, Inc. |
Automated pipetting apparatus having a combined liquid pump and pipette head system
|
US8105783B2
(en)
|
2007-07-13 |
2012-01-31 |
Handylab, Inc. |
Microfluidic cartridge
|
US9186677B2
(en)
|
2007-07-13 |
2015-11-17 |
Handylab, Inc. |
Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples
|
US8182763B2
(en)
|
2007-07-13 |
2012-05-22 |
Handylab, Inc. |
Rack for sample tubes and reagent holders
|
US8354280B2
(en)
*
|
2007-09-06 |
2013-01-15 |
Bioscale, Inc. |
Reusable detection surfaces and methods of using same
|
ES2640216T3
(es)
|
2007-12-07 |
2017-11-02 |
Miltenyi Biotec Gmbh |
Sistemas y métodos para procesamiento de células
|
US20110275985A1
(en)
*
|
2008-07-03 |
2011-11-10 |
T2 Biosystems, Inc. |
Magnetic nanosensor compositions and bioanalytical assays therefor
|
WO2010056337A2
(en)
|
2008-11-12 |
2010-05-20 |
Caris Mpi, Inc. |
Methods and systems of using exosomes for determining phenotypes
|
EP2359164A4
(de)
*
|
2008-12-10 |
2012-05-30 |
Abqmr Inc |
Kernmagnetresonanzgerät, verfahren und zugehörige technologie
|
EP2230515B1
(de)
*
|
2009-03-16 |
2014-12-17 |
Agilent Technologies, Inc. |
Passivierung von Oberflächen nach Ligandenkupplung
|
US8790916B2
(en)
*
|
2009-05-14 |
2014-07-29 |
Genestream, Inc. |
Microfluidic method and system for isolating particles from biological fluid
|
JP5270486B2
(ja)
*
|
2009-07-31 |
2013-08-21 |
トヨタ自動車株式会社 |
ナノ物質集積体の製造方法、ナノ物質集積体およびそれを用いたデバイス、ならびにナノ物質の構造解析方法
|
US20140148348A1
(en)
|
2010-01-13 |
2014-05-29 |
Christine Kuslich |
Dectection of gastrointestinal disorders
|
JP5808349B2
(ja)
|
2010-03-01 |
2015-11-10 |
カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー |
セラノーシスのためのバイオマーカー
|
BR112012025593A2
(pt)
|
2010-04-06 |
2019-06-25 |
Caris Life Sciences Luxembourg Holdings |
biomarcadores em circulação para doença
|
US9476812B2
(en)
|
2010-04-21 |
2016-10-25 |
Dna Electronics, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
US9428547B2
(en)
|
2010-04-21 |
2016-08-30 |
Dna Electronics, Inc. |
Compositions for isolating a target analyte from a heterogeneous sample
|
US20110262989A1
(en)
|
2010-04-21 |
2011-10-27 |
Nanomr, Inc. |
Isolating a target analyte from a body fluid
|
US8841104B2
(en)
|
2010-04-21 |
2014-09-23 |
Nanomr, Inc. |
Methods for isolating a target analyte from a heterogeneous sample
|
JP5960146B2
(ja)
|
2010-10-14 |
2016-08-02 |
ジャンセン ダイアグノスティックス,エルエルシー |
多特異性捕捉試薬及び混合検出試薬を用いる膵臓患者の循環腫瘍細胞を検出する方法及びキット
|
CA3082652A1
(en)
|
2011-04-15 |
2012-10-18 |
Becton, Dickinson And Company |
Scanning real-time microfluidic thermocycler and methods for synchronized thermocycling and scanning optical detection
|
DE102011050550A1
(de)
*
|
2011-05-20 |
2012-11-22 |
Wolfgang Göhde |
Verfahren und Anordnung zur Quantifizierung von Untergruppen aus einer Mischpopulation von Zellen
|
WO2013006774A1
(en)
|
2011-07-07 |
2013-01-10 |
Veridex, Llc |
Genomic diagnostics using circulating endothelial cells
|
JP2013224289A
(ja)
*
|
2011-10-15 |
2013-10-31 |
Canon Inc |
粒子及び前記粒子を有する光音響イメージング用造影剤、センチネルリンパ節用造影剤
|
EP2773892B1
(de)
|
2011-11-04 |
2020-10-07 |
Handylab, Inc. |
Vorrichtung zur vorbereitung von polynukleotidproben
|
BR112014015424A2
(pt)
|
2011-12-23 |
2018-05-22 |
Depuy Synthes Products Llc |
detecção de células derivadas de tecido do cordão umbilical humano
|
EP2805987A4
(de)
|
2012-01-18 |
2015-09-09 |
Rbc Bioscience Corp |
Verfahren zur herstellung eines magnetpartikelverbundstoffes
|
US10942184B2
(en)
|
2012-10-23 |
2021-03-09 |
Caris Science, Inc. |
Aptamers and uses thereof
|
ES2912033T3
(es)
|
2012-10-23 |
2022-05-24 |
Caris Science Inc |
Aptámeros y usos de los mismos
|
US9434940B2
(en)
|
2012-12-19 |
2016-09-06 |
Dna Electronics, Inc. |
Methods for universal target capture
|
US9804069B2
(en)
|
2012-12-19 |
2017-10-31 |
Dnae Group Holdings Limited |
Methods for degrading nucleic acid
|
US10000557B2
(en)
|
2012-12-19 |
2018-06-19 |
Dnae Group Holdings Limited |
Methods for raising antibodies
|
US9599610B2
(en)
|
2012-12-19 |
2017-03-21 |
Dnae Group Holdings Limited |
Target capture system
|
EP2935628B1
(de)
|
2012-12-19 |
2018-03-21 |
Caris Life Sciences Switzerland Holdings GmbH |
Zusammensetzungen und verfahren für aptamer-screening
|
US9995742B2
(en)
|
2012-12-19 |
2018-06-12 |
Dnae Group Holdings Limited |
Sample entry
|
US9551704B2
(en)
|
2012-12-19 |
2017-01-24 |
Dna Electronics, Inc. |
Target detection
|
RU2507155C1
(ru)
*
|
2012-12-28 |
2014-02-20 |
Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Национальный исследовательский технологический университет "МИСиС" |
Способ получения наночастиц магнетита, стабилизированных поливиниловым спиртом
|
KR20160080815A
(ko)
|
2013-08-28 |
2016-07-08 |
카리스 라이프 사이언스 스위스 홀딩스 게엠베하 |
올리고뉴클레오티드 프로브 및 이의 용도
|
WO2015128725A1
(en)
*
|
2014-02-28 |
2015-09-03 |
Dh Technologies Development Pte. Ltd. |
Magnetic elements for processing fluids
|
CN113046312A
(zh)
|
2014-04-23 |
2021-06-29 |
朱诺治疗学股份有限公司 |
分离、培养和遗传工程改造用于过继治疗的免疫细胞群的方法
|
MA40253A
(fr)
|
2014-07-15 |
2017-05-24 |
Juno Therapeutics Inc |
Cellules modifiées pour thérapie cellulaire adoptive
|
TWI751102B
(zh)
|
2014-08-28 |
2022-01-01 |
美商奇諾治療有限公司 |
對cd19具專一性之抗體及嵌合抗原受體
|
ES2879612T3
(es)
|
2014-10-20 |
2021-11-22 |
Juno Therapeutics Inc |
Métodos y composiciones para dosificación en terapia celular adoptiva
|
MA40318A
(fr)
|
2014-11-05 |
2017-09-13 |
Juno Therapeutics Inc |
Procédés de transduction et de traitement de cellules
|
MX2017007138A
(es)
|
2014-12-03 |
2017-08-28 |
Juno Therapeutics Inc |
Metodos y composiciones para terapia celular adoptiva.
|
MA41346A
(fr)
|
2015-01-12 |
2017-11-21 |
Juno Therapeutics Inc |
Eléments régulateurs post-transcriptionnels d'hépatite modifiée
|
US20160208018A1
(en)
|
2015-01-16 |
2016-07-21 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for ror1
|
DE102015101834A1
(de)
|
2015-02-09 |
2016-08-11 |
Technische Universität Ilmenau |
Verfahren und Vorrichtung zur Detektion und Lokalisierung von mikrostimulierten Partikeln
|
CA2979361A1
(en)
|
2015-03-09 |
2016-09-15 |
Caris Science, Inc. |
Method of preparing oligonucleotide libraries
|
WO2016166568A1
(en)
|
2015-04-16 |
2016-10-20 |
Juno Therapeutics Gmbh |
Methods, kits and apparatus for expanding a population of cells
|
CN107614458B
(zh)
|
2015-05-01 |
2021-05-11 |
百进生物科技公司 |
稳定的纳米磁性颗粒分散体
|
CA2986060A1
(en)
|
2015-05-29 |
2016-12-08 |
Valerie Odegard |
Composition and methods for regulating inhibitory interactions in genetically engineered cells
|
WO2017004243A1
(en)
|
2015-06-29 |
2017-01-05 |
Caris Science, Inc. |
Therapeutic oligonucleotides
|
MA42895A
(fr)
|
2015-07-15 |
2018-05-23 |
Juno Therapeutics Inc |
Cellules modifiées pour thérapie cellulaire adoptive
|
WO2017019918A1
(en)
|
2015-07-28 |
2017-02-02 |
Caris Science, Inc. |
Targeted oligonucleotides
|
US20180251810A1
(en)
|
2015-09-11 |
2018-09-06 |
Bacteria Detection Ltd |
Methods for isolating microbial cells from a blood sample
|
CN116875635A
(zh)
|
2015-10-22 |
2023-10-13 |
朱诺治疗学有限公司 |
用于转导的方法、反应剂盒、反应剂和设备
|
MA45488A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés, kits et appareil de culture de cellules
|
MA45489A
(fr)
|
2015-10-22 |
2018-08-29 |
Juno Therapeutics Gmbh |
Procédés de culture de cellules, kits et appareil associés
|
MA44314A
(fr)
|
2015-11-05 |
2018-09-12 |
Juno Therapeutics Inc |
Récepteurs chimériques contenant des domaines induisant traf, et compositions et méthodes associées
|
US11020429B2
(en)
|
2015-11-05 |
2021-06-01 |
Juno Therapeutics, Inc. |
Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapy
|
MA43378A
(fr)
|
2015-12-03 |
2018-10-10 |
Juno Therapeutics Inc |
Compositions et méthodes pour la reduction de la réponse immunitaire contre récepteurs d'antigène chimériques
|
AU2016363025B2
(en)
|
2015-12-03 |
2021-04-08 |
Juno Therapeutics, Inc. |
Modified chimeric receptors and related compositions and methods
|
MA43377A
(fr)
|
2015-12-04 |
2021-05-19 |
Hutchinson Fred Cancer Res |
Méthodes et compositions liées à la toxicité associée à la thérapie cellulaire
|
CN108601731A
(zh)
|
2015-12-16 |
2018-09-28 |
磨石肿瘤生物技术公司 |
新抗原的鉴别、制造及使用
|
EP3430548A1
(de)
|
2016-03-16 |
2019-01-23 |
Juno Therapeutics, Inc. |
Verfahren zur bestimmung der dosierung eines therapeutikums und verwandte behandlungen
|
EP3430549A1
(de)
|
2016-03-16 |
2019-01-23 |
Juno Therapeutics, Inc. |
Verfahren zum adaptiven design eines behandlungsplans und ähnlicher behandlungen
|
EP4339288A2
(de)
|
2016-03-18 |
2024-03-20 |
Caris Science, Inc. |
Oligonukleotidsonden und verwendungen davon
|
EP4015536A1
(de)
|
2016-03-22 |
2022-06-22 |
Seattle Children's Hospital (DBA Seattle Children's Research Institute) |
Frühinterventionsverfahren zur vermeidung oder verbesserung von toxizität
|
CN109312293B
(zh)
|
2016-04-30 |
2022-09-16 |
百进生物科技公司 |
用于进行磁浮分离的组合物和方法
|
AU2017271579B2
(en)
|
2016-05-25 |
2023-10-19 |
Caris Science, Inc. |
Oligonucleotide probes and uses thereof
|
CA3026453A1
(en)
|
2016-06-03 |
2017-12-07 |
Memorial Sloan-Kettering Cancer Center |
Adoptive cell therapies as early treatment options
|
MA45341A
(fr)
|
2016-06-06 |
2019-04-10 |
Hutchinson Fred Cancer Res |
Procédés de traitement de malignités de lymphocytes b au moyen d'une thérapie cellulaire adoptive
|
CA3028002A1
(en)
|
2016-06-27 |
2018-01-04 |
Juno Therapeutics, Inc. |
Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
|
MA45491A
(fr)
|
2016-06-27 |
2019-05-01 |
Juno Therapeutics Inc |
Épitopes à restriction cmh-e, molécules de liaison et procédés et utilisations associés
|
ES2926513T3
(es)
|
2016-07-29 |
2022-10-26 |
Juno Therapeutics Inc |
Métodos para evaluar la presencia o ausencia de virus competente en replicación
|
CN110088133B
(zh)
|
2016-07-29 |
2023-12-08 |
朱诺治疗学股份有限公司 |
抗独特型抗体及相关方法
|
MX2019001185A
(es)
|
2016-07-29 |
2019-10-21 |
Juno Therapeutics Inc |
Polipeptidos inmunomoduladores y composiciones y metodos relacionados.
|
EP3957997A1
(de)
|
2016-08-26 |
2022-02-23 |
Juno Therapeutics, Inc. |
Verfahren zur zählung von partikeln in einer zellzusammensetzung
|
CA3035829A1
(en)
|
2016-09-12 |
2018-03-15 |
Juno Therapeutics, Inc. |
Perfusion bioreactor bag assemblies
|
CN110139873A
(zh)
|
2016-10-03 |
2019-08-16 |
朱诺治疗学股份有限公司 |
Hpv特异性结合分子
|
US11896615B2
(en)
|
2016-10-13 |
2024-02-13 |
Juno Therapeutics, Inc. |
Immunotherapy methods and compositions involving tryptophan metabolic pathway modulators
|
WO2018085731A2
(en)
|
2016-11-03 |
2018-05-11 |
Juno Therapeutics, Inc. |
Combination therapy of a t cell therapy and a btk inhibitor
|
US20190292246A1
(en)
|
2016-11-03 |
2019-09-26 |
Juno Therapeutics, Inc. |
Combination therapy of a cell based therapy and a microglia imhibitor
|
CN110494565A
(zh)
|
2016-12-02 |
2019-11-22 |
朱诺治疗学股份有限公司 |
工程化b细胞及相关组合物和方法
|
MA46995A
(fr)
|
2016-12-03 |
2019-10-09 |
Acerta Pharma Bv |
Méthodes et compositions pour l'utilisation de lymphocytes t thérapeutiques en association avec des inhibiteurs de kinase
|
CA3045508A1
(en)
|
2016-12-03 |
2018-06-07 |
Juno Therapeutics, Inc. |
Methods for modulation of car-t cells
|
US20200078400A1
(en)
|
2016-12-03 |
2020-03-12 |
Juno Therapeutics, Inc. |
Methods for determining car-t cells dosing
|
JP2019536461A
(ja)
|
2016-12-05 |
2019-12-19 |
ジュノー セラピューティクス インコーポレイテッド |
養子細胞療法のための操作細胞の産生
|
AU2018207305A1
(en)
|
2017-01-10 |
2019-07-25 |
Juno Therapeutics, Inc. |
Epigenetic analysis of cell therapy and related methods
|
CN110418802A
(zh)
|
2017-01-20 |
2019-11-05 |
朱诺治疗学有限公司 |
细胞表面缀合物及相关的细胞组合物和方法
|
CA3052779A1
(en)
|
2017-02-17 |
2018-08-23 |
Fred Hutchinson Cancer Research Center |
Combination therapies for treatment of bcma-related cancers and autoimmune disorders
|
BR112019017767A2
(pt)
|
2017-02-27 |
2020-04-07 |
Juno Therapeutics Inc |
composições, artigos de fabricação e métodos relacionados à dosagem em terapia celular
|
AU2018234640B2
(en)
|
2017-03-14 |
2024-03-14 |
Juno Therapeutics, Inc. |
Methods for cryogenic storage
|
WO2018187791A1
(en)
|
2017-04-07 |
2018-10-11 |
Juno Therapeutics, Inc |
Engineered cells expressing prostate-specific membrane antigen (psma) or a modified form thereof and related methods
|
AU2018251188A1
(en)
|
2017-04-14 |
2019-10-31 |
Juno Therapeutics, Inc. |
Methods for assessing cell surface glycosylation
|
BR112019022356A2
(pt)
|
2017-04-27 |
2020-05-26 |
Juno Therapeutics Gmbh |
Reagentes de partícula oligoméricos e métodos de uso dos mesmos
|
CA3061945A1
(en)
|
2017-05-01 |
2018-11-08 |
Juno Therapeutics, Inc. |
Combination of a cell therapy and an immunomodulatory compound
|
WO2018223101A1
(en)
|
2017-06-02 |
2018-12-06 |
Juno Therapeutics, Inc. |
Articles of manufacture and methods for treatment using adoptive cell therapy
|
MA48781A
(fr)
|
2017-06-02 |
2020-04-08 |
Juno Therapeutics Inc |
Articles de fabrication et procédés liés à la toxicité associée à la thérapie cellulaire
|
JP2020526194A
(ja)
|
2017-06-29 |
2020-08-31 |
ジュノー セラピューティクス インコーポレイテッド |
免疫療法薬と関連する毒性を評価するためのマウスモデル
|
BR112020001719A2
(pt)
|
2017-07-29 |
2020-07-21 |
Juno Therapeutics Inc |
reagentes para expansão de células que expressam receptores recombinantes
|
ES2959953T3
(es)
|
2017-08-09 |
2024-02-29 |
Juno Therapeutics Inc |
Métodos para producir composiciones celulares genéticamente modificadas y composiciones relacionadas
|
BR112020001601A2
(pt)
|
2017-08-09 |
2020-08-11 |
Juno Therapeutics Inc |
métodos e composições para preparar células geneticamente manipuladas
|
MA50057A
(fr)
|
2017-09-01 |
2020-07-08 |
Juno Therapeutics Inc |
Expression génique et évaluation d'un risque de développement d'une toxicité suite à une thérapie cellulaire
|
WO2019051335A1
(en)
|
2017-09-07 |
2019-03-14 |
Juno Therapeutics, Inc. |
METHODS OF IDENTIFYING CELLULAR CHARACTERISTICS RELATED TO RESPONSES ASSOCIATED WITH CELL THERAPY
|
CA3080546A1
(en)
|
2017-10-03 |
2019-04-11 |
Juno Therapeutics, Inc. |
Hpv-specific binding molecules
|
KR20200087143A
(ko)
|
2017-10-10 |
2020-07-20 |
그릿스톤 온콜로지, 인코포레이티드 |
핫스팟을 이용한 신생항원 동정
|
WO2019089848A1
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods associated with tumor burden for assessing response to a cell therapy
|
KR20200116077A
(ko)
|
2017-11-01 |
2020-10-08 |
주노 쎄러퓨티크스 인코퍼레이티드 |
B 세포 성숙 항원에 특이적인 키메라 항원 수용체 및 암호화 폴리뉴클레오타이드
|
MA50855A
(fr)
|
2017-11-01 |
2020-09-09 |
Juno Therapeutics Inc |
Procédé de génération de compositions thérapeutiques de cellules modifiées
|
CA3080904A1
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for b-cell maturation antigen
|
SG11202003657VA
(en)
|
2017-11-01 |
2020-05-28 |
Juno Therapeutics Inc |
Process for producing a t cell composition
|
WO2019089858A2
(en)
|
2017-11-01 |
2019-05-09 |
Juno Therapeutics, Inc. |
Methods of assessing or monitoring a response to a cell therapy
|
WO2019090364A1
(en)
|
2017-11-06 |
2019-05-09 |
Juno Therapeutics, Inc. |
Combination of a cell therapy and a gamma secretase inhibitor
|
WO2019094835A1
(en)
|
2017-11-10 |
2019-05-16 |
Juno Therapeutics, Inc. |
Closed-system cryogenic vessels
|
CA3083097A1
(en)
|
2017-11-22 |
2019-05-31 |
Gritstone Oncology, Inc. |
Reducing junction epitope presentation for neoantigens
|
CN111989106A
(zh)
|
2017-12-01 |
2020-11-24 |
朱诺治疗学股份有限公司 |
基因工程化细胞的给药和调节方法
|
KR20200109308A
(ko)
|
2017-12-08 |
2020-09-22 |
주노 쎄러퓨티크스 인코퍼레이티드 |
세포 요법을 위한 표현형 마커 및 관련 방법
|
MX2020005908A
(es)
|
2017-12-08 |
2020-10-07 |
Juno Therapeutics Inc |
Proceso para producir una composicion de celulas t modificadas.
|
BR112020011144A2
(pt)
|
2017-12-08 |
2020-11-17 |
Juno Therapeutics Inc |
formulação de meio livre de soro para o cultivo de células e métodos de uso da mesma
|
EP3724225A1
(de)
|
2017-12-15 |
2020-10-21 |
Juno Therapeutics, Inc. |
Anti-cct5-bindende moleküle und verfahren zur verwendung davon
|
JP2021511802A
(ja)
|
2018-01-31 |
2021-05-13 |
ジュノー セラピューティクス インコーポレイテッド |
複製可能ウイルスの存在または非存在を評価するための方法および試薬
|
JP7383620B2
(ja)
|
2018-01-31 |
2023-11-20 |
セルジーン コーポレイション |
養子細胞療法およびチェックポイント阻害剤を使用する併用療法
|
WO2019169194A1
(en)
|
2018-02-28 |
2019-09-06 |
Juno Therapeutics, Inc. |
Methods for detecting particles present in a cell composition
|
WO2019170845A1
(en)
|
2018-03-09 |
2019-09-12 |
Ospedale San Raffaele S.R.L. |
Il-1 antagonist and toxicity induced by cell therapy
|
CN112566698A
(zh)
|
2018-04-05 |
2021-03-26 |
朱诺治疗学股份有限公司 |
T细胞受体和表达该t细胞受体的工程化细胞
|
MX2020010461A
(es)
|
2018-04-05 |
2021-01-15 |
Juno Therapeutics Inc |
Linfocitos t que expresan un receptor recombinante, polinucleotidos y metodos relacionados.
|
EP3775238A1
(de)
|
2018-04-05 |
2021-02-17 |
Juno Therapeutics, Inc. |
Verfahren zur herstellung von zellen, die einen rekombinanten rezeptor exprimieren, und verwandte zusammensetzungen
|
CA3098497A1
(en)
|
2018-05-03 |
2019-11-07 |
Juno Therapeutics, Inc. |
Combination therapy of a chimeric antigen receptor (car) t cell therapy and a kinase inhibitor
|
EP3790832A4
(de)
|
2018-05-08 |
2021-05-05 |
Biomagnetic Solutions LLC |
Starre kammer zur zelltrennung aus einem flexiblen einwegbeutel
|
EP3807305A4
(de)
|
2018-06-13 |
2022-04-20 |
Akron Biotechnology, LLC |
Verfahren zur herstellung von therapeutisch wirksamem aldesleukin, das in flüssigen pharmazeutischen zusammensetzungen hochstabil ist
|
US20210230671A1
(en)
|
2018-08-09 |
2021-07-29 |
Juno Therapeutics, Inc. |
Methods for assessing integrated nucleic acids
|
US20210163893A1
(en)
|
2018-08-09 |
2021-06-03 |
Juno Therapeutics, Inc. |
Processes for generating engineered cells and compositions thereof
|
CA3110905A1
(en)
|
2018-08-31 |
2020-03-05 |
Invectys SA |
Chimeric antigen receptors against multiple hla-g isoforms
|
CN113167796A
(zh)
|
2018-09-11 |
2021-07-23 |
朱诺治疗学股份有限公司 |
对工程化细胞组合物进行质谱分析的方法
|
WO2020092848A2
(en)
|
2018-11-01 |
2020-05-07 |
Juno Therapeutics, Inc. |
Methods for treatment using chimeric antigen receptors specific for b-cell maturation antigen
|
WO2020092854A2
(en)
|
2018-11-01 |
2020-05-07 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for g protein-coupled receptor class c group 5 member d (gprc5d)
|
EP3877054B1
(de)
|
2018-11-06 |
2023-11-01 |
Juno Therapeutics, Inc. |
Verfahren zur herstellung von genetisch veränderten t-zellen
|
AU2019377854A1
(en)
|
2018-11-08 |
2021-05-27 |
Juno Therapeutics, Inc. |
Methods and combinations for treatment and T cell modulation
|
JP2022513062A
(ja)
|
2018-11-16 |
2022-02-07 |
ジュノー セラピューティクス インコーポレイテッド |
B細胞悪性腫瘍を処置するために、操作されたt細胞を投薬する方法
|
JP2022513685A
(ja)
|
2018-11-30 |
2022-02-09 |
ジュノー セラピューティクス インコーポレイテッド |
養子細胞療法を用いた処置のための方法
|
MX2021006244A
(es)
|
2018-11-30 |
2021-09-10 |
Juno Therapeutics Inc |
Metodos de dosificacion y tratamiento de canceres de celulas b en terapia celular adoptiva.
|
PE20212198A1
(es)
|
2019-01-29 |
2021-11-16 |
Juno Therapeutics Inc |
Anticuerpos y receptores quimericos de antigenos especificos para receptor 1 huerfano tipo receptor tirosina-cinasa (ror1)
|
AU2020265741A1
(en)
|
2019-05-01 |
2021-11-25 |
Editas Medicine, Inc. |
Cells expressing a recombinant receptor from a modified TGFBR2 Locus, related polynucleotides and methods
|
MX2021013223A
(es)
|
2019-05-01 |
2022-02-17 |
Juno Therapeutics Inc |
Celulas que expresan un receptor quimerico de un locus cd247 modificado, polinucleotidos relacionados y metodos.
|
US20220249637A1
(en)
|
2019-06-12 |
2022-08-11 |
Juno Therapeutics, Inc. |
Combination therapy of a cell-mediated cytotoxic therapy and an inhibitor of a prosurvival bcl2 family protein
|
WO2021035194A1
(en)
|
2019-08-22 |
2021-02-25 |
Juno Therapeutics, Inc. |
Combination therapy of a t cell therapy and an enhancer of zeste homolog 2 (ezh2) inhibitor and related methods
|
WO2021041994A2
(en)
|
2019-08-30 |
2021-03-04 |
Juno Therapeutics, Inc. |
Machine learning methods for classifying cells
|
WO2021092097A1
(en)
|
2019-11-05 |
2021-05-14 |
Juno Therapeutics, Inc. |
Methods of determining attributes of therapeutic t cell compositions
|
US20220401483A1
(en)
|
2019-11-07 |
2022-12-22 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and (s)-3-[4-(4-morpholin-4-ylmethyl-benzyloxy)-l-oxo-l,3-dihydro-isoindol-2-yl]-piperidine-2,6-dione
|
JP2023504740A
(ja)
|
2019-12-06 |
2023-02-06 |
ジュノー セラピューティクス インコーポレイテッド |
Bcma標的結合ドメインに対する抗イディオタイプ抗体ならびに関連する組成物および方法
|
WO2021113780A1
(en)
|
2019-12-06 |
2021-06-10 |
Juno Therapeutics, Inc. |
Anti-idiotypic antibodies to gprc5d-targeted binding domains and related compositions and methods
|
JP2023504737A
(ja)
|
2019-12-06 |
2023-02-06 |
ジュノー セラピューティクス インコーポレイテッド |
B細胞性悪性疾患を処置するための細胞療法と関連する毒性および奏効に関係する方法
|
AU2021209940A1
(en)
|
2020-01-24 |
2022-08-04 |
Juno Therapeutics, Inc. |
Methods for dosing and treatment of follicular lymphoma and marginal zone lymphoma in adoptive cell therapy
|
WO2021154887A1
(en)
|
2020-01-28 |
2021-08-05 |
Juno Therapeutics, Inc. |
Methods for t cell transduction
|
JP2023519099A
(ja)
|
2020-02-12 |
2023-05-10 |
ジュノー セラピューティクス インコーポレイテッド |
Bcma指向性キメラ抗原受容体t細胞組成物ならびにその方法および使用
|
EP4103204A1
(de)
|
2020-02-12 |
2022-12-21 |
Juno Therapeutics, Inc. |
Cd19-gerichtete chimäre antigen-rezeptor-t-zell-zusammensetzungen und verfahren und verwendungen davon
|
KR20230009386A
(ko)
|
2020-04-10 |
2023-01-17 |
주노 쎄러퓨티크스 인코퍼레이티드 |
B-세포 성숙 항원을 표적화하는 키메라 항원 수용체로 조작된 세포 요법 관련 방법 및 용도
|
EP4142723A2
(de)
|
2020-04-28 |
2023-03-08 |
Juno Therapeutics, Inc. |
Kombination aus bcma-gerichteter t-zelltherapie und einer immunmodulatorischen verbindung
|
KR20230022868A
(ko)
|
2020-05-13 |
2023-02-16 |
주노 쎄러퓨티크스 인코퍼레이티드 |
재조합 수용체를 발현하는 공여자-배치 세포의 제조 방법
|
JP2023528215A
(ja)
|
2020-05-13 |
2023-07-04 |
ジュノー セラピューティクス インコーポレイテッド |
臨床応答に関連する特徴量の特定方法およびその使用
|
WO2021260186A1
(en)
|
2020-06-26 |
2021-12-30 |
Juno Therapeutics Gmbh |
Engineered t cells conditionally expressing a recombinant receptor, related polynucleotides and methods
|
EP4192868A1
(de)
|
2020-08-05 |
2023-06-14 |
Juno Therapeutics, Inc. |
Antiidiotypische antikörper gegen ror1-gerichtete bindungsdomänen und zugehörige zusammensetzungen und verfahren
|
WO2022098787A1
(en)
|
2020-11-04 |
2022-05-12 |
Juno Therapeutics, Inc. |
Cells expressing a chimeric receptor from a modified invariant cd3 immunoglobulin superfamily chain locus and related polynucleotides and methods
|
WO2022133030A1
(en)
|
2020-12-16 |
2022-06-23 |
Juno Therapeutics, Inc. |
Combination therapy of a cell therapy and a bcl2 inhibitor
|
CN117693508A
(zh)
|
2021-03-03 |
2024-03-12 |
朱诺治疗学股份有限公司 |
T细胞疗法和dgk抑制剂的组合
|
KR20230159851A
(ko)
|
2021-03-22 |
2023-11-22 |
주노 쎄러퓨티크스 인코퍼레이티드 |
치료 세포 조성물의 효력을 결정하는 방법
|
WO2022212384A1
(en)
|
2021-03-29 |
2022-10-06 |
Juno Therapeutics, Inc. |
Combination of a car t cell therapy and an immunomodulatory compound for treatment of lymphoma
|
WO2022212400A1
(en)
|
2021-03-29 |
2022-10-06 |
Juno Therapeutics, Inc. |
Methods for dosing and treatment with a combination of a checkpoint inhibitor therapy and a car t cell therapy
|
KR20230171468A
(ko)
|
2021-04-16 |
2023-12-20 |
셀진 코포레이션 |
Bcma-지시된 t 세포 요법과의 조합 요법
|
CN113281500B
(zh)
*
|
2021-05-21 |
2022-07-12 |
深圳市光与生物科技有限公司 |
一种用于单分子检测的磁珠及其制备方法
|
WO2023081735A1
(en)
|
2021-11-03 |
2023-05-11 |
Celgene Corporation |
Chimeric antigen receptors specific for b-cell maturation antigen for use in treating myeloma
|
WO2023081900A1
(en)
|
2021-11-08 |
2023-05-11 |
Juno Therapeutics, Inc. |
Engineered t cells expressing a recombinant t cell receptor (tcr) and related systems and methods
|
WO2023147515A1
(en)
|
2022-01-28 |
2023-08-03 |
Juno Therapeutics, Inc. |
Methods of manufacturing cellular compositions
|
WO2023164440A1
(en)
|
2022-02-22 |
2023-08-31 |
Juno Therapeutics, Inc. |
Proteinase 3 (pr3) chimeric autoantibody receptor t cells and related methods and uses
|
WO2023220655A1
(en)
|
2022-05-11 |
2023-11-16 |
Celgene Corporation |
Methods to overcome drug resistance by re-sensitizing cancer cells to treatment with a prior therapy via treatment with a t cell therapy
|
WO2023230548A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Method for predicting response to a t cell therapy
|
WO2023230581A1
(en)
|
2022-05-25 |
2023-11-30 |
Celgene Corporation |
Methods of manufacturing t cell therapies
|
WO2023250400A1
(en)
|
2022-06-22 |
2023-12-28 |
Juno Therapeutics, Inc. |
Treatment methods for second line therapy of cd19-targeted car t cells
|
WO2024006960A1
(en)
|
2022-06-29 |
2024-01-04 |
Juno Therapeutics, Inc. |
Lipid nanoparticles for delivery of nucleic acids
|
WO2024031091A2
(en)
|
2022-08-05 |
2024-02-08 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for gprc5d and bcma
|
WO2024044779A2
(en)
|
2022-08-26 |
2024-02-29 |
Juno Therapeutics, Inc. |
Antibodies and chimeric antigen receptors specific for delta-like ligand 3 (dll3)
|
WO2024054944A1
(en)
|
2022-09-08 |
2024-03-14 |
Juno Therapeutics, Inc. |
Combination of a t cell therapy and continuous or intermittent dgk inhibitor dosing
|